Minimal important difference in childhood interstitial lung diseases

BACKGROUND: Monitoring disease progression in childhood interstitial lung diseases (chILD) is essential. No information for the minimal important difference (MID), which is defined as the smallest change in a parameter that is perceived as important prompting a clinician to change the treatment, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Griese, Matthias, Schwerk, Nicolaus, Carlens, Julia, Wetzke, Martin, Emiralioğlu, Nagehan, Kiper, Nural, Lange, Joanna, Krenke, Katarzyna, Seidl, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Paediatric Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176404/
https://www.ncbi.nlm.nih.gov/pubmed/36572533
http://dx.doi.org/10.1136/thorax-2022-219206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176404/
https://www.ncbi.nlm.nih.gov/pubmed/36572533
http://dx.doi.org/10.1136/thorax-2022-219206

Ejemplares similares